Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AngioDynamics Introduces New Line of Drainage Catheters.


QUEENSBURY, N.Y.--(BW HealthWire)--Nov. 24, 1999--

The Product Line Will be Formally Announced At the Annual

Meeting of the Radiological Society of North America The Radiological Society of North America (RSNA), founded in 1915, has the purpose to "promote and develop the highest standards of radiology and related sciences through education and research".  

AngioDynamics, Inc., a wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
 of E-Z-EM, Inc. (Amex: EZM.A and EZM.B) announced today that it has launched in the United States its general fluid drainage catheter line, trade named ABSCESSION(TM).

The product is currently released for general sale in the United States and will be formally announced at the 85th annual meeting of the Radiological Society of North America (RSNA RSNA Radiological Society of North America, Inc.
RSNA Robust Security Network Association
), November 28-December 3, in Chicago. This product will be shown at E-Z-EM booth No. 2145.

The new product line features a locking pigtail A cable that has an appropriate connector on one end and loose wires on the other. It is designed to patch into an existing line or to terminate the ends of a long run. Contrast with patch cord.  design in all sizes needed to perform a percutaneous fluid drainage procedure. AngioDynamics developed the product line in 6, 8, 10 and 12 French sizes and in 15cm and 30cm lengths. The locking pigtail design, in conjunction with the wide range of French sizes, addresses the clinical needs to treat fluid collections. The Company estimates the worldwide market for drainage catheters is in excess of $90 million annually.

Mr. Eamonn Hobbs, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , said, "The ABSCESSION(TM) Drainage Catheter improves AngioDynamics' position as a vital supplier to our customer, the Interventional Radiologist. Abscess abscess, localized inflamation associated with tissue necrosis. Abscesses are characterized by inflamation, which is due to the accumulation of pus in the local tissues, and often painful swelling.  and fluid drainage is a key service provided by Interventional Radiologists. The addition of this product line will allow these practitioners another choice of devices and give them more reasons for choosing AngioDynamics as their supplier of choice."

The ABSCESSION(TM) Drainage Catheter features a proprietary surface treatment (Blue Silk(TM)) that makes the insertion of the catheter very smooth and effortless. An excellent tip taper further aids the ease of insertion. Special attention has been paid to the locking mechanism to make it tamper-resistant and very comfortable for the patient, an important consideration due to the fact these catheters can be in place for weeks and even months. The 6 French catheter size can be used with standard 0.035-inch guidewires instead of special guidewires required by competitive products. Another major benefit is that the catheter material will immediately recover its full inner lumen even if severely bent or twisted.

AngioDynamics strategy is to focus product development efforts solely based on the needs of Interventional Radiologists. In addition to the already released ABSCESSION(TM) Drainage Catheter, the Company intends to market its WorkHorse(TM) PTA PTA or parent-teacher association: see parent education.  balloon catheter balloon catheter
n.
A catheter with an inflatable balloon at its tip, used especially to expand a partially obstructed blood vessel or bodily passage and to measure blood pressure in a blood vessel. Also called balloon-tip catheter.
 and VistaFlex(TM) platinum stent which are cleared for sale in the United States for a biliary indication. This group of new products, added to the Company's well-recognized portfolio of angiographic catheters, thrombolytic drug delivery systems, electromechanical injectors, vascular access vascular access Clinical medicine The ability to enter the vascular system; the ease with which the vascular system can be entered for administering therapy or obtaining blood for testing  devices and carbon dioxide systems, places AngioDynamics as a full-service provider to the global Interventional Radiology community.

The statements made in this press release contain certain forward-looking statements that involve a number of risks and uncertainties. Actual events or results may differ from the Company's expectations. In addition to matters described in this release, future actions by the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
, results of pending or future clinical trials, as well as the risk factors listed from time to time in the SEC filings of E-Z-EM, Inc., including but not limited to its Form 10-Q for the quarter ended August 28, 1999, as well as its Annual Report on Form 10-K, may affect the actual results achieved by the Company.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 24, 1999
Words:553
Previous Article:Lumisys Announces the Introduction of the ACR-2000i.
Next Article:Neoware Systems, Inc. Comments On Possible Nasdaq National Market Delisting.
Topics:



Related Articles
AngioDynamics Announces New Line of Biliary Stents; The Product Line Will be Formally Announced at the Annual Meeting of the Radiological Society of...
AngioDynamics Signs Distribution Agreement With HDC Corporation.
Engineering Out the Risk for Infection with Urinary Catheters.
AngioDynamics Introduces New Biliary Drainage Catheter.
AngioDynamics Introduces ACCU-VU Sizing Angiographic Catheters.
Leg and Drainage Bags. (Product Spotlight).
Percutaneous drainage for treatment of infected pancreatic pseudocysts. (Original Article).
AngioDynamics Comments on Patent Infringement Lawsuit Related to VenaCure Laser Products.
AngioDynamics Announces Launch of the TOTAL ABSCESSION General Drainage Catheter.
Minimally invasive transoral catheter-assisted drainage of a danger-space infection.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles